Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Combination of palbociclib with navitoclax based-therapies enhances in vivo antitumoral activity in triple-negative breast cancer
Composition Active Agent: Benzyl Alcohol 0.9% (bacteriostatic preservative) Base: Sterile Water Volume: 10ml per vial pH: 4.57.0 Container: Sealed glass vial with rubber septum and aluminium crimp cap Manufactured in: Spain ISO 13485:2016 + GMP + ISO 9001:2016 certified facility Intended use: Research Use Only (RUO) not for clinical use In-use period: Up to 28 days after first puncture with aseptic technique Storage Store unopened vials at room temperature (15-25C)
From Wikipedia, the free encyclopedia FOXO4-DRI is a synthetic peptide derivative that is described as an all D-enantiomer retro-inverso peptide [1] It blocks the activity of Forkhead box protein O4 (FOXO4), a transcription factor which is elevated in senescent cells, and helps maintain their viability
However, consult your doctor about any supplements youre taking to avoid potential interactions
What Is BPC-157, and How Does It Work
US$ 20.74
US$ 28.93
US$ 25.40
US$ 29.82
US$ 24.90
US$ 26.64
US$ 25.99
US$ 28.18
US$ 29.37
